You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Treatment as Prevention

  • Authors: Myron S. Cohen, MD; David J. Malebranche, MD, MPH; Leandro A. Mena, MD, MPH
  • CME / ABIM MOC / CE Released: 7/25/2019; Reviewed and Renewed: 7/27/2021
  • Valid for credit through: 7/27/2022
Start Activity

Target Audience and Goal Statement

This activity is intended for primary care physicians, infectious diseases/HIV specialists, and public health and preventive medicine specialists.

The goal of this activity is to improve knowledge regarding the benefits of treatment as prevention (TasP) for patients living with HIV and the best practices for implementing TasP in clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Data supporting TasP
    • Key barriers/disparities, particularly within the South, that may hinder adoption of TasP
    • Available resources and tools that can be used to facilitate TasP
  • Demonstrate greater confidence in their ability to
    • Effectively communicate the benefits of treatment for individuals, their loved ones, and/or sex partners


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Myron S. Cohen, MD

    DiYeargan-Bate Professor of Medicine Microbiology and Epidemiology
    Associate Vice Chancellor for Medical Affairs and Global Health
    Institute for Global Health and Infectious Diseases
    Division of Infectious Diseases
    University of North Carolina at Chapel Hill


    Disclosure: Myron S. Cohen, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Gilead Sciences, Inc.; Merck & Co., Inc.

  • Leandro A. Mena, MD, MPH

    Professor and Chair
    Population Health Science and Medicine
    University of Mississippi Medical Center
    Jackson, Mississippi


    Disclosure: Leandro A. Mena, MD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbott; Gilead Sciences, Inc.; Merck & Co., Inc.; Viiv Healthcare
    Served as a speaker or a member of a speakers bureau for: Gilead Sciences, Inc.; Viiv Healthcare
    Received grants for clinical research from: Atlas Pharma; Evofem Biosciences, Inc.; GlaxoSmithKline; Hologic, Inc.; Viiv Healthcare

  • David J. Malebranche, MD, MPH

    Associate Professor of Medicine
    Student Employee Health Services
    Morehouse School of Medicine
    Atlanta, Georgia


    Disclosure: David J. Malebranche, MD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Gilead Sciences
    Served as a speaker or a member of a speakers bureau for: Gilead Sciences


  • Sara Fagerlie, PhD, CHCP

    Senior Scientific Director, Medscape, LLC


    Disclosure: Sara Fagerlie, PhD, CHCP, has disclosed no relevant financial relationships. 

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance
    Medscape, LLC


    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number JA0007105-0000-21-438-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Treatment as Prevention


Contents of this CME/CE Activity

All sections of this activity are required for credit.

Section 1. Treatment as Prevention: Understanding the Data

Dr Cohen discusses key clinical data related to TasP and how to adopt a comprehensive approach to HIV prevention.
Myron S. Cohen, MD

Section 2. Treatment as Prevention: Challenges and Opportunities

Dr Mena reviews the challenges to adopting TasP in the community and individual patients, and opportunities to overcome these barriers.
Leandro A. Mena, MD, MPH

Section 3. Treatment as Prevention: Having the Conversation – Engaging and Educating Patients

Dr Malebranche and Ms Traylor demonstrate strategies to adapt TasP into clinical practice and facilitate adoption within the patient community.
David J. Malebranche, MD, MPH and Masonia Traylor

Educational Impact Challenge

The goal of this activity is to improve knowledge regarding the benefits of treatment as prevention (TasP) for patients living with HIV and the best practices for implement TasP in clinical practice.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print